Patterns of Utilization and Expenditure Across Multiple Sclerosis Disease-Modifying Therapies: A Retrospective Cohort Study Using Claims Data from a Commercially Insured Population in the United States, 2010 –2019
ConclusionDMT cost is a key driver of the overall healthcare expenditure in MS. Future comparative and cost-effectiveness studies integrating claims and electronic health records data with better balancing of patient characteristics are warranted.
Source: Neurology and Therapy - Category: Neurology Source Type: research
More News: Brain | Electronic Health Records (EHR) | Emergency Medicine | Healthcare Costs | Insurance | MRI Scan | Multiple Sclerosis | Neurology | Study | Tysabri | USA Health | Women